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Insulin-like growth factor 1 receptor (IGF1R) acts as a critical mediator of cell proliferation and survival. Many single nucleotide
polymorphisms (SNPs) found in the IGF1R gene have been associated with various diseases, including both breast and prostate
cancer. The genetics of these diseases could be better understood by knowing the functions of these SNPs. In this study, we
performed acomprehensive analysis of thefunctional and structuralimpactofall known SNPs inthis gene usingpublicly available
computational prediction tools. Out of a total of 2412SNPs in IGF1R retrieved from dbSNP, we found 32nsSNPs, 58sSNPs,
83mRNA 3  UTR SNPs, and 2225 intronic SNPs. Among the nsSNPs, a total of six missense nsSNPs were found to be damaging
by both a sequence homology-based tool (SIFT) and a structural homology-based method (PolyPhen), and one nonsense nsSNP
was found. Further, we modeled mutant proteins and compared the total energy values with the native IGF1R protein, and showed
that a mutation from arginine to cysteine at position 1216 (rs61740868) on the surface of the protein caused the greatest impact
on stability. Also, the FASTSNP tool suggested that 31sSNPs and 3 intronic SNPs might aﬀect splicing regulation. Based on our
investigation, we report potential candidate SNPs for future studies on IGF1R mutations.
1.Introduction
Single nucleotide polymorphisms (SNPs) are DNA sequence
variations that occur when a single nucleotide (A, T, C,
or G) in the genome is altered. SNPs make up about 90%
of all human genetic variation, occurring every 100–300
basesalongthe3-billion-basehumangenome,althoughtheir
density vary between regions [1]. SNPs are found in both
coding (gene) and noncoding regions of the genome. Many
SNPs have no eﬀect on cell function; however, others could
predispose people to disease or inﬂuence their response
to a drug. Nonsynonymous SNPs (nsSNPs) that lead to
an amino acid residue substitution in the protein product
are of particular interest because they are responsible for
nearly half of the known genetic variations related to human
inheriteddisease[2].CodingsynonymousSNPs(sSNPs)and
SNPs occurring outside gene promoter or coding regions
may nevertheless still have consequencesfor gene expression,
splicing, or transcription-factor binding [3, 4].
The identiﬁcation of SNPs responsible for speciﬁc phe-
n o t y p e sa p p e a r st ob eap r o b l e mt h a ti sv e r yd i ﬃcult to
solve, requiring multiple testing of hundreds or thousands of
SNPs in candidate genes [5]. However, the question of how
to choose the set of SNPs to be screened is critical to the
success of association studies. A possible way to overcome
this problem would be to prioritize SNPs according to
their functional signiﬁcance [6, 7] by using Bioinformatics
prediction tools, which may help discriminate neutral SNPs
from SNPs of likely functional importance and could also
be useful to reveal the structural basis of disease mutations.
Without any careful preselection of SNPs to be screened,
a huge number of individuals might be required to detect
association at a reasonable level of statistical signiﬁcance [5].2 Journal of Biomedicine and Biotechnology
Although wetlab-based approaches used to identify
disease-associated SNPs from a large number of neutral
SNPs remain crucial evidence for the functional role of
SNPs [8], numerous disease associations published could
not be conﬁrmed by subsequent independent studies [6,
9]. Hence, independent evidence of functionality of SNPs
obtained by using prediction tools could also serve as
additional argument to discriminate true associations from
false positives [5], as shown recently by the functional SNP
analysisoftheBRCA1,ABL1,ERBB2,CFTR,andEGFRgenes
[10–14].
Insulin-like growth factor 1 receptor (IGF1R) is a growth
factor receptor tyrosine kinase that acts as a critical mediator
of cell proliferation and survival. This receptor is implicated
in several cancers, including both breast and prostate cancer
[15, 16]. Evidence suggests that IGF1R signaling is required
for survival and growth when prostate cancer cells progress
to androgen independence [17], as increased levels of the
receptor are expressed in the majority of primary and
metastatic prostate cancer patient tumors [18]. There have
also been studies showing associations of IGF1R polymor-
phisms in dementia and ischemic stroke [19, 20].
Although there are presently several articles describing
the association of SNPs in the IGF1R gene with diﬀerent
types of diseases, computational analysis has not yet been
undertaken on the functional consequences of SNPs in this
gene. We applied diﬀerent publicly available computational
algorithms, namely, Sorting Intolerant From Tolerant (SIFT)
[21], Polymorphism Phenotyping (PolyPhen) [22], and
Function Analysis and selection tool for single nucleotide
polymorphisms (FASTSNP) to identify likely deleterious
SNPs which could aﬀect protein function [23].
The SIFT algorithm predicts whether an amino acid
substitution aﬀects protein function based on sequence
homology among related genes and domains over evolu-
tionary time, and the physical-chemical properties of the
amino acid residues [24–26]. Sequence conservation and
the nature of the amino acid residues involved are also
incorporated by PolyPhen, but it also values the location
of the substitution within known structures and structural
features of the protein available in the annotated database
SwissProt [5, 27]. By accessing a variety of heterogeneous
biological databases and analytical tools, FASTSNP is able to
identify SNPs most likely to have functional eﬀects, such as
changes to the transcriptional level and pre-mRNA splicing
[23].
SIFTandPolyPhenwereapproximately80%successfulin
benchmarking studies employing amino acid substitutions
assumed to have a major negative impact on the residual
activity of the variant protein as the test set [22, 25, 27–
29] and it has been estimated that the “false negative” and
“false positive” error rates of SIFT is 31% and 20%, and 31%
and 9% for PolyPhen [26]. FASTSNP was used to analyze
1569SNPs from the SNP500 cancer database, and results
showed that SNPs with a high predicted risk exhibited low
allele frequencies for the minor alleles, which is consistent
with the ﬁnding that a strong selective pressure exist for
functional polymorphisms [23, 30].
As the majority of disease mutations aﬀect protein sta-
bility [31, 32], we also proposed modeled protein structures
for the mutant proteins and compared them with the native
protein in order to evaluate stability changes.
2.MaterialsandMethods
2.1. Evaluation of the Functional Impact of Coding nsSNPs
Using a Sequence Homology Tool (SIFT). SIFT takes a query
sequenceandusesmultiplealignmentinformationtopredict
tolerated and deleterious substitutions for every position of
the query sequence (http://sift.jcvi.org)[ 21]. It is a multistep
procedure that, given a protein sequence, (1) searches for
similar sequences, (2) chooses closely related sequences
that may share similar function, (3) obtains the multiple
alignment of these chosen sequences, and (4) calculates
normalized probabilities for all possible substitutions at each
position from the alignment. Substitutions at each position
with normalized probabilities less than a tolerance index
of 0.05 are predicted to be intolerant or deleterious; those
greater than or equal to 0.05 are predicted to be tolerated
[24, 26].
The analysis was performed by allowing the algorithm to
search for homologous sequences using the default settings
(UniProt-TrEMBL 39.6 database, median conservation of
sequences of 3.00, and allowance to remove sequences more
than 90% identical to query sequence). The IGF1R FASTA
amino acid sequence of the NCBI Protein accession id
NP 000866.1 was used as the query sequence, and a total
of 24IGF1RnsSNPs ﬁltered from the dbSNP database were
analyzed.
2.2. Evaluation of the Functional Impact of Coding nsSNPs
Using a Structural Homology-Based Method (PolyPhen).
PolyPhen prediction is based on straightforward empir-
ical rules which are applied to the sequence, phy-
logenetic and structural information characterizing the
substitution [5]. The online input form available at
http://coot.embl.de/PolyPhen was ﬁlled with the IGF1R
amino acid sequence in FASTA format (NCBI Protein acces-
sion id NP 000866.1), and the position and substitution of
each of the 24nsSNPs analyzed by SIFT were also submitted
forPolyPhenanalysis.PolyPhenthensearchedfor3Dprotein
structures, multiple alignments of homologous sequences
and amino acid contact information in several protein
structuredatabases,calculatedposition-speciﬁcindependent
counts (PSIC) scores for each of the two amino acid residues
entered (the original residue and the nsSNP), and then
computed the PSIC scores diﬀerence of the two residues.
The higher a PSIC score diﬀerence, the higher functional
impact a particular amino acid substitution is likely to have.
A PSIC score diﬀerence of 1.5 and above is considered to be
damaging. The query options were left with default values.
2.3. Functional Signiﬁcance of SNPs in Regulatory Regions.
The online tool FASTSNP [23] was used to determine the
impact of the sSNPs, 3  UTR regions SNPs and intronicJournal of Biomedicine and Biotechnology 3
Table 1: List of nsSNPs that were analysed by SIFT and PolyPhen.
dbSNP ID Alleles AA change Tolerance index PSIC Heterozygosity Validation
rs70958401 C/T Arg/Trp 0.18 1.892 0.039
rs70958396 G/A Ala/Thr 0.41 0.011 0.039
rs61740877 G/A Val/Ile 0.77 0.019 n/a
rs61740868 C/T Arg/Cys 0.00 2.609 n/a 1
rs61731172 G/A Arg/Gln 0.74 0.137 n/a
rs56248469 G/A Arg/His 0.57 0.613 n/a
rs45611935 A/G Asn/Ser 0.77 0.387 n/a
rs45597432 T/C Ile/Thr 0.96 0.079 n/a
rs45578132 T/C Val/Ala 0.00 2.027 n/a
rs45553041 G/A Arg/His 0.00 2.196 0.012
rs45526336 G/A Glu/Lys 0.00 1.470 n/a
rs45524940 A/G Thr/Ala 0.01 2.296 n/a
rs45522834 C/T Thr/Ile 0.29 1.220 n/a
rs45512296 G/A Arg/His 0.01 2.128 n/a
rs45504297 T/C Leu/Pro 0.00 2.372 n/a
rs45493995 G/T Ser/Ile 0.30 0.400 n/a
rs45475702 G/A Val/Ile 0.55 0.296 n/a
rs45451896 G/T Arg/Leu 0.25 0.305 n/a
rs45445894 G/A Val/Met 0.03 0.947 0.011
rs35224135 G/A Ala/Thr 0.31 1.026 0.005 2
rs34516635 G/A Arg/His 1.00 1.339 0.005 1; 2
rs34102392 G/A Ala/Thr 0.17 1.097 n/a
rs34061581 A/G His/Arg 0.25 1.346 0.005 2
rs33958176 G/A Arg/Gln 0.59 1.503 n/a 1; 2
Prediction scores found to be functionally signiﬁcant by SIFT and PolyPhen are shown in bold.Validation Status Description: (1) validated by multiple,
independent submissions to the refSNP cluster; (2) validated by frequency or genotype data: minor alleles observed in at least two chromosomes.
SNPs on the regulation of the IGF1R gene. The FAST-
SNP server (http://FASTSNP.ibms.sinica.edu.tw) follows the
decision tree principle with external Web service access to
TFSearch, which predicts whether a non-coding SNP alters
the transcription factor binding site of a gene. The score is
given on the basis of levels of risk with a ranking of 0, 1, 2, 3,
4, or 5. This signiﬁes the levels of no, very low, low, medium,
high, and very high eﬀect, respectively.
2.4. Modeling of nsSNPs on Protein Structures and Calculation
of their RMSD Diﬀerence. Structural analysis was performed
in order to evaluate and compare the stability of native
and mutant structures. Information about mapping the
nsSNPs in the protein structure was obtained from dbSNP
[33]. The highest resolution (2.00 ˚ A) native structure of
the IGF1R protein available in the Protein Data Bank
(PDB) [34] has an id of 2oj9 [35]. The positions of the
studied nsSNPs mutations on PDBid 2oj9 were conﬁrmed
by pairwise alignment between the FASTA amino acid
sequence of the IGF1R protein obtained from the NCBI
(NP 000866.1) and the 2oj9 FASTA amino acid sequence,
using the Sequence Manipulation Suite [36]. The amino
acid residue substitutions were performed using the Swiss-
Pdb Viewer [37], followed by energy minimization of the
modeled 3D structures using the GROMACS software ver-
sion 4.0 [38]. The algorithms used for energy minimization
were the steepest descent (1000 steps), followed by conjugate
gradient (1500 steps) alternating with the steepest descent
every100steps.Thecomparisonbetweentheresultingnative
and modeled structures was made by the calculation of the
potential energy and RMSD values.
3. Results and Discussion
3.1. SNP Dataset. Polymorphism data of the IGF1R gene
investigated in this paper was retrieved from the dbSNP
database [33]. It contained a total of 2412SNPs, out of which
32 (1.3%) were nsSNPs, 58 (2.4%) were sSNPs, 83 (3.4%)
occurred in the mRNA 3  UTR, and 2225 (92.2%) occurred
in intronic regions. SNPs in the 5  UTR region were not
found. It can be seen from the distribution in Figure 1 that
the vast majority of SNPs occur in the intronic region, and
that there are more 3  UTR region SNPs than nsSNPs or
sSNPs. We selected missense nsSNPs, sSNPs, 3  UTR SNPs,
and intronic SNPs for our investigation.
3.2. Deleterious nsSNPs by SIFT Program. Protein sequence
with mutational position and amino acid residue variants
associated to 24 missense nsSNPs were submitted as input
to the SIFT server, and the results are shown in Table 1,
along with the corresponding heterozygosity and valida-
tion status description for each SNP, when available from4 Journal of Biomedicine and Biotechnology
Table 2: List of SNPs predicted to be functionally signiﬁcant by FASTSNP.
dbSNP ID Nucleotide
change
Region Level of risk Possible
functional eﬀect
Heterozygosity Validation
rs45437300 A/T coding Very High-Very High (5-5) Nonsense n/a
rs55895813 A/G intronic Medium-High (3-4) Splicing site n/a
rs36108138 A/C intronic Medium-High (3-4) Splicing site n/a
rs45495500 C/T intronic Medium-High (3-4) Splicing site n/a
rs34226328 C/T coding Low-Medium (2-3) Splicing
regulation
0.006 2
rs35041862 C/G coding Low-Medium (2-3) Splicing
regulation
0.017 2
rs55770488 C/T coding Low-Medium (2-3) Splicing
regulation
n/a
rs35385418 A/G coding Low-Medium (2-3) Splicing
regulation
0.022 1; 2
rs45504194 A/G coding Low-Medium (2-3) Splicing
regulation
n/a
rs45582234 G/T coding Low-Medium (2-3) Splicing
regulation
0.012
rs17847210 G/T coding Low-Medium (2-3) Splicing
regulation
n/a 1
rs56013396 C/T coding Low-Medium (2-3) Splicing
regulation
n/a
rs35171849 C/T coding Low-Medium (2-3) Splicing
regulation
0.011 1; 2
rs35812156 A/C coding Low-Medium (2-3) Splicing
regulation
n/a 1
rs55954954 C/T coding Low-Medium (2-3) Splicing
regulation
n/a
rs45506098 C/T coding Low-Medium (2-3) Splicing
regulation
0.013 1; 4; 5
rs45598332 G/T coding Low-Medium (2-3) Splicing
regulation
0.013
rs45615734 C/T coding Low-Medium (2-3) Splicing
regulation
n/a
rs45486504 C/G coding Low-Medium (2-3) Splicing
regulation
n/a
rs3743262 C/T coding Low-Medium (2-3) Splicing
regulation
0.255 1; 4; 5
rs45627636 A/G coding Low-Medium (2-3) Splicing
regulation
n/a
rs45443393 A/G coding Low-Medium (2-3) Splicing
regulation
0.011
rs45459793 A/G coding Low-Medium (2-3) Splicing
regulation
n/a
rs56400113 C/T coding Low-Medium (2-3) Splicing
regulation
n/a
rs35449468 C/T coding Low-Medium (2-3) Splicing
regulation
0.006 1
rs17847208 C/T coding Low-Medium (2-3) Splicing
regulation
0.005 1; 2
rs2229765 A/G coding Low-Medium (2-3) Splicing
regulation
0.458 1; 2; 3; 4
rs28664854 A/G coding Low-Medium (2-3) Splicing
regulation
n/a
rs35362396 C/T coding Low-Medium (2-3) Splicing
regulation
0.005Journal of Biomedicine and Biotechnology 5
Table 2: Continued.
dbSNP ID Nucleotide
change
Region Level of risk Possible
functional eﬀect
Heterozygosity Validation
rs45598038 C/T coding Low-Medium (2-3) Splicing
regulation
n/a 1
rs34364279 C/T coding Low-Medium (2-3) Splicing
regulation
0.006
rs45468291 C/T coding Low-Medium (2-3) Splicing
regulation
n/a
rs56020698 C/T coding Low-Medium (2-3) Splicing
regulation
n/a
rs17847203 C/T coding Low-Medium (2-3) Splicing
regulation
0.170 1; 2
rs45453791 C/T coding Low-Medium (2-3) Splicing
regulation
0.039 1
Validation Status Description: (1) Validated by multiple, independent submissions to the refSNP cluster; (2) Validated by frequency or genotype data: minor
alleles observed in at least two chromosomes; (3) All alleles have been observed in at least two chromosomes apiece; (4) Genotyped by HapMap project; (5)
SNP has been sequenced in 1000 Genome project.
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Figure 1: Distribution of IGF1R non-synonymous SNPs (nsSNPs),
synonymous SNPs (sSNPs), 3  UTR SNPs, and intronic SNPs.
dbSNP. According to the classiﬁcation proposed by Ng and
Henikoﬀ [24]a n dX ie ta l .[ 28], the lower the tolerance
index, the higher the functional impact a particular amino
acid residue substitution is likely to have and vice versa.
Among the 24nsSNPs analyzed, 8nsSNPs were identiﬁed
to be deleterious with a tolerance index score ≤0.05. Five
nsSNPs (rs61740868, rs45578132, rs45553041, rs45526336,
and rs45504297) showed a highly deleterious tolerance index
score of 0.00. The remaining deleterious nsSNPs showed
tolerance index scores of 0.01 (rs45524940 and rs45512296)
and 0.03 (rs45445894). Four deleterious nsSNPs showed a
nucleotide change from G/A, four a change from C/T, two
a change from T/C, and one a change from A/G.
3.3. Damaged nsSNPs by PolyPhen Server. All the 24 protein
sequences of missense nsSNPs submitted to SIFT were also
submitted to the PolyPhen server. A PSIC score diﬀerence
of 1.5 and above is considered to be damaging. Eight
nsSNPs (rs70958401, rs61740868, rs45578132, rs45504297,
rs45553041, rs45512296, rs45524940, and rs33958176) were
considered to be damaging and exhibited a range of PSIC
score diﬀerence between 1.503 and 2.609 (Table 1). Out
of these damaging nsSNPs, two changed from positively
charged amino acid in the native protein to hydrophobic
amino acid in the mutant type, two from aliphatic nonpolar
amino acid to non-polar amino acid, two from positively
charged amino acid to aromatic positively charged amino
acid, one from polar amino acid to non-polar amino acid,
and one from positively charged to polar amino acid,
respectively. It can be seen from Table 1 that there was
signiﬁcant correlation between the results obtained from
the evolutionary-based approach SIFT and the structural-
based approach PolyPhen for six nsSNPs predicted to be
damaging by PolyPhen, suggesting that these nsSNPs may
disrupt both the protein function and structure. The most
damagingnsSNP(rs61740868)showedaPSICscoreof2.609,
due to a mutation from arginine to cysteine.
3.4. SNPs in Regulatory Regions. According to FASTSNP, out
of 58sSNPs in the IGF1R gene, 31sSNPs were predicted
to be damaging with a risk ranking of 2-3, and a possible
functional eﬀect on splicing regulation (Table 2). Among
these, the A/G polymorphism (rs2229765) has been shown
experimentally to aﬀect the susceptibility to ischemic stroke
in Chinese population [19] to be associated with higher
plasma concentrations of circulating IGF1R and premature
pubarche [39, 40] and adult height variation in the human
population [41]. Out of 2225SNPs which occur in the
intronic region of the IGF1R gene, 3SNPs (rs55895813,
rs36108138 and rs45495500) were predicted to aﬀect the
splicing site (3-4 risk) (Table 2).
I tc a nb es e e nf r o mTable 2 that a coding nonsense SNP
(rs45437300) due to a nucleotide change from A to T was
detected and showed a very high (5-5) level of risk, as it
can truncate and even inactivate the IGF1R protein, causing
disease as a result.6 Journal of Biomedicine and Biotechnology
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Figure 2: (a) Native structure (2jo9) showing arginine at position
1216. (b) Mutant modeled structure (2jo9 R1216C) showing
cysteine residue at position 1216. (c) Superimposed structure of
native structure (2jo9) (green) with mutant modeled structure
(2jo9 R1216C) (gray).
3.5. Structural Analysis of Mutant Structures. Out of eight
nsSNPspredictedtobedeleteriousbySIFTorPolyPhen,four
(rs61740868, rs45526336, rs45512296, and rs45504297) were
mapped to the PDB ID 2oj9 native structure. The amino
acid residue substitutions were performed by Swiss-Pdb
Viewer independently to get four mutant modeled structures
(2oj9 R1216C, 2oj9 E1253K, 2oj9 R1216H, and 2oj9 L1211P,
respectively). Then, energy minimizations were performed
byGROMACSforthenative structure(2oj9) andthemutant
modeled structures.
Table 3: RMSD and total energy of native structure (2jo9) and
mutant modeled structures.
dbSNP ID Amino Acid
change
RMSD between
native and
mutant
structures
Total energy
after
minimization
(KJ/mol)
rs61740868 Arg1216Cys 0,48 −13343.28
rs45526336 Glu1253Lys 0,38 −13887.05
rs45512296 Arg1216His 0,46 −13483.34
rs45504297 Leu1211Pro 0,22 −13782.33
Total energy of native structure (2jo9) after energy minimization:
−13841.67.
The total energy for the native structure (2oj9) and the
four mutant modeled structures 2oj9 R1216C, 2oj9 E1253K,
2oj9 R1216H, and 2oj9 L1211P was −13841.67, −13343.28,
−13887.05, −13483.34, and −13782.33 KJ/mol, respectively
(Table 3).Threeoutoffourmutantmodeledstructures(2oj9
R1216C,2oj9R1216H,and2oj9L1211P)showedanincrease
in energy (less favorable change) in comparison with the
native structure. This result correlates with the structural
homology method (PolyPhen) results, which predicted all
these three mutants to be deleterious (PSIC scores 2.609,
2.128, and 2.372, resp.) (Table 1). The mutant model 2oj9
R1216C showed the greatest increase in energy, which may
be explained by the energetically unfavorable substitution of
a positively charged arginine amino acid residue to a non-
polarcysteineaminoacidresidueatthesurfaceoftheprotein
structure (Figure 2).
It can be seen from Table 3 that the RMSD values
between the native structure (2oj9) and the mutant modeled
structures are all similar, ranging from 0.22 ˚ At o0 . 4 8˚ A.
Because these values are low, we can suggest that these
mutations do not cause a signiﬁcant change in the mutant
structures with respect to the native protein structure.
4. Conclusion
In this paper, we investigated the functional and structural
impact of SNPs in the IGF1R gene using computational
prediction tools. Out of a total of 2412SNPs in the IGF1R
gene, 32SNPs were found to be non-synonymous, 58 were
synonymous, 83 occurred in the mRNA 3  UTR, and
2225 were found in intronic regions. Out of 24 missense
nsSNPs, eight were found to be deleterious by SIFT, and
eight were found to be damaging by the PolyPhen tool. A
total of six nsSNPs were found to be damaging by both
SIFT and PolyPhen tools. The structural analysis results
showed that the amino acid residue substitutions which had
the greatest impact on the stability of the IGF1R protein
were mutations 2oj9 R1216C (rs61740868) and R1216H
(rs45512296). Among the nsSNPs studied, a nonsense SNP
(rs45437300) was found. Out of 58sSNPs, 31 were predicted
to aﬀect splicing regulation by FASTSNP, including an sSNP
(rs2229765) associated with several diseases. In the intronic
region, 3SNPs (rs55895813, rs36108138, and rs45495500)
were predicted to aﬀect splicing regulation. Based on ourJournal of Biomedicine and Biotechnology 7
results, we conclude that these SNPs should be considered
important candidates in causing diseases related to IGF1R
malfunction.
Acknowledgments
This work was supported by an FAPEMIG fellowship (S.A.
de Alencar) and a CNPQ grant (J.C.D. Lopes).
References
[ 1 ] J . - E .L e e ,J .H .C h o i ,J .H .L e e ,a n dM .G .L e e ,“ G e n eS N P sa n d
mutations in clinical genetic testing: haplotype-based testing
and analysis,” Mutation Research, vol. 573, no. 1-2, pp. 195–
204, 2005.
[ 2 ]M .K r a w c z a k ,E .V .B a l l ,I .F e n t o ne ta l . ,“ H u m a ng e n e
mutation database—a biomedical information and research
resource,” Human Mutation, vol. 15, no. 1, pp. 45–51, 2000.
[3] L. Prokunina and M. E. Alarc´ on-Riquelme, “Regulatory
SNPs in complex diseases: their identiﬁcation and functional
validation,” Expert Reviews in Molecular Medicine, vol. 6, no.
10, 2004.
[ 4 ]P .D .S t e n s o n ,M .M o r t ,E .V .B a l l ,e ta l . ,“ T h eh u m a ng e n e
mutationdatabase:2008update,”GenomeMedicine,vol.1,no.
1, p. 13, 2009.
[5] V. Ramensky, P. Bork, and S. Sunyaev, “Human non-
synonymous SNPs: server and survey,” Nucleic Acids Research,
vol. 30, no. 17, pp. 3894–3900, 2002.
[6] T. Emahazion, L. Feuk, M. Jobs et al., “SNP association studies
in Alzheimer’s disease highlight problems for complex disease
analysis,” Trends in Genetics, vol. 17, no. 7, pp. 407–413, 2001.
[ 7 ] N .J .S c h o r k ,D .F a l l i n ,a n dJ .S .L a n c h b u r y ,“ S i n g l en u c l e o t i d e
polymorphisms and the future of genetic epidemiology,”
Clinical Genetics, vol. 58, no. 4, pp. 250–264, 2000.
[8] C. G. P. Doss, C. Sudandiradoss, R. Rajasekaran et al.,
“Applications of computational algorithm tools to identify
functional SNPs,” Functional and Integrative Genomics, vol. 8,
no. 4, pp. 309–316, 2008.
[9] N. J. Risch, “Searching for genetic determinants in the new
millennium,” Nature, vol. 405, no. 6788, pp. 847–856, 2000.
[10] R. Rajasekaran, C. Sudandiradoss, C. G. P. Doss, and R.
Sethumadhavan, “Identiﬁcation and in silico analysis of
functional SNPs of the BRCA1 gene,” Genomics, vol. 90, no.
4, pp. 447–452, 2007.
[11] C. G. P. Doss, C. Sudandiradoss, R. Rajasekaran, R. Purohit,
K. Ramanathan, and R. Sethumadhavan, “Identiﬁcation and
structural comparison of deleterious mutations in nsSNPs of
ABL1 gene in chronic myeloid leukemia: a bio-informatics
study,” Journal of Biomedical Informatics,v o l .4 1 ,n o .4 ,p p .
607–612, 2008.
[12] R. Rajasekaran, C. G. P. Doss, C. Sudandiradoss, K.
Ramanathan, R. Purohit, and R. Sethumadhavan, “Eﬀect
of deleterious nsSNP on the HER2 receptor based on sta-
bility and binding aﬃnity with herceptin: a computational
approach,” C o m p t e sR e n d u sB i o l o g i e s , vol. 331, no. 6, pp. 409–
417, 2008.
[13] C. G. P. Doss, R. Rajasekaran, C. Sudandiradoss, K.
Ramanathan, R. Purohit, and R. Sethumadhavan, “A novel
computational and structural analysis of nsSNPs in CFTR
gene,” Genomic Medicine, vol. 2, no. 1-2, pp. 23–32, 2008.
[14] R. Rajasekaran and R. Sethumadhavan, “In Silico identi-
ﬁcation of signiﬁcant detrimental missense mutations of
EGFRandtheireﬀectwith4-anilinoquinazoline-baseddrugs,”
Applied Biochemistry and Biotechnology, vol. 160, no. 6, pp.
1723–1733, 2010.
[15] G. S. Warshamana-Greene, J. Litz, E. Buchdunger, C. Garc´ ıa-
Echeverr´ ıa, F. Hofmann, and G. W. Krystal, “The insulin-
like growth factor-I receptor kinase inhibitor, NVP-ADW742,
sensitizes small cell lung cancer cell lines to the eﬀects of
chemotherapy,” Clinical Cancer Research, vol. 11, no. 4, pp.
1563–1571, 2005.
[16] H. E. Jones, L. Goddard, J. M. W. Gee et al., “Insulin-like
growth factor-I receptor signalling and acquired resistance to
geﬁtinib (ZD1839; Iresa) in human breast and prostate cancer
cells,” Endocrine-Related Cancer, vol. 11, no. 4, pp. 793–814,
2004.
[17] S. L. Krueckl, R. A. Sikes, N. M. Edlund et al., “Increased
insulin-like growth factor I receptor expression and signaling
are components of androgen-independent progression in a
lineage-derived prostate cancer progression model,” Cancer
Research, vol. 64, no. 23, pp. 8620–8629, 2004.
[18] G. O. Hellawell, G. D. H. Turner, D. R. Davies, R. Poulsom,
S. F. Brewster, and V. M. Macaulay, “Expression of the type 1
insulin-like growth factor receptor is up-regulated in primary
prostate cancer and commonly persists in metastatic disease,”
Cancer Research, vol. 62, no. 10, pp. 2942–2950, 2002.
[19] J. Cheng, J. Liu, X. Li, et al., “Insulin-like growth factor-1
receptor polymorphism and ischemic stroke: a case-control
study in Chinese population,” Acta Neurologica Scandinavica,
vol. 118, no. 5, pp. 333–338, 2008.
[20] J. Garcia, A. Ahmadi, A. Wonnacott, et al., “Association
of insulin-like growth factor-1 receptor polymorphism in
dementia,”DementiaandGeriatricCognitiveDisorders,vol.22,
no. 5-6, pp. 439–444, 2006.
[21] P.C.NgandS.Henikoﬀ,“SIFT:predictingaminoacidchanges
that aﬀect protein function,” Nucleic Acids Research, vol. 31,
no. 13, pp. 3812–3814, 2003.
[22] S. Sunyaev, V. Ramensky, and P. Bork, “Towards a structural
basis of human non-synonymous single nucleotide polymor-
phisms,” Trends in Genetics, vol. 16, no. 5, pp. 198–200, 2000.
[23] H.-Y. Yuan, J.-J. Chiou, W.-H. Tseng et al., “FASTSNP: an
always up-to-date and extendable service for SNP function
analysis and prioritization,” Nucleic Acids Research, vol. 34, pp.
W635–W641, 2006.
[24] P. C. Ng and S. Henikoﬀ, “Predicting deleterious amino acid
substitutions,” Genome Research, vol. 11, no. 5, pp. 863–874,
2001.
[25] P. C. Ng and S. Henikoﬀ, “Accounting for human polymor-
phismspredictedtoaﬀectproteinfunction,”GenomeResearch,
vol. 12, no. 3, pp. 436–446, 2002.
[26] P. C. Ng and S. Henikoﬀ, “Predicting the eﬀects of amino acid
substitutionsonproteinfunction,”AnnualReviewofGenomics
and Human Genetics, vol. 7, pp. 61–80, 2006.
[27] S. Sunyaev, W. Lathe III, and P. Bork, “Integration of genome
data and protein structures: prediction of protein folds,
protein interactions and “molecular phenotypes” of single
nucleotide polymorphisms,” Current Opinion in Structural
Biology, vol. 11, no. 1, pp. 125–130, 2001.
[28] T. Xi,I. M.Jones, and H. W. Mohrenweiser, “Many amino acid
substitution variants identiﬁed in DNA repair genes during
human population screenings are predicted to impact protein
function,” Genomics, vol. 83, no. 6, pp. 970–979, 2004.
[29] D. Chasman and R. M. Adams, “Predicting the functional
consequences of non-synonymous single nucleotide polymor-
phisms: structure-based assessment of amino acid variation,”
JournalofMolecularBiology,vol.307,no.2,pp.683–706,2001.8 Journal of Biomedicine and Biotechnology
[30] M. Cargill, D. Altshuler, J. Ireland et al., “Characterization of
single-nucleotide polymorphisms in coding regions of human
genes,” Nature Genetics, vol. 22, no. 3, pp. 231–238, 1999.
[31] Z. Wang and J. Moult, “SNPs, protein structure, and disease,”
Human Mutation, vol. 17, no. 4, pp. 263–270, 2001.
[32] N. Tokuriki, F. Stricher, L. Serrano, and D. S. Tawﬁk,
“How protein stability and new functions trade oﬀ,” PLoS
Computational Biology, vol. 4, no. 2, Article ID e1000002,
2008.
[33] S. T. Sherry, M.-H. Ward, M. Kholodov et al., “DbSNP: the
NCBI database of genetic variation,” Nucleic Acids Research,
vol. 29, no. 1, pp. 308–311, 2001.
[34] H. M. Berman, J. Westbrook, Z. Feng et al., “The protein data
bank,”NucleicAcidsResearch,vol.28,no.1,pp.235–242,2000.
[35] U. Velaparthi, M. Wittman, P. Liu et al., “Discovery and initial
SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as
inhibitors of insulin-like growth factor 1-receptor (IGF-1R),”
Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 8, pp.
2317–2321, 2007.
[36] P. Stothard, “The sequence manipulation suite: JavaScript
programs for analyzing and formatting protein and DNA
sequences,” BioTechniques, vol. 28, no. 6, pp. 1102–1104, 2000.
[37] N. Guex, A. Diemand, and M. C. Peitsch, “Protein modelling
for all,” Trends in Biochemical Sciences, vol. 24, no. 9, pp. 364–
366, 1999.
[38] B. Hess, C. Kutzner, D. van der Spoel, and E. Lindahl,
“GRGMACS 4: algorithms for highly eﬃcient, load-balanced,
and scalable molecular simulation,” Journal of Chemical
Theory and Computation, vol. 4, no. 3, pp. 435–447, 2008.
[39] M. Bonaf` e, M. Barbieri, F. Marchegiani et al., “Polymorphic
variants of insulin-like growth factor I (IGF-I) receptor and
phosphoinositide3-kinasegenesaﬀectIGF-Iplasmalevelsand
human longevity: cues for an evolutionarily conserved mech-
anism of life span control,” Journal of Clinical Endocrinology
and Metabolism, vol. 88, no. 7, pp. 3299–3304, 2003.
[40] M. B. Roldan, C. White, and S. F. Witchel, “Association of the
GAA1013→GAG polymorphism of the insulin-like growth
factor-1 receptor (IGF1R) gene with premature pubarche,”
Fertility and Sterility, vol. 88, no. 2, pp. 410–417, 2007.
[41] V. M. Chia, L. C. Sakoda, B. I. Graubard et al., “Risk of
testicular germ cell tumors and polymorphisms in the insulin-
likegrowthfactorgenes,”CancerEpidemiologyBiomarkersand
Prevention, vol. 17, no. 3, pp. 721–726, 2008.